文献速递病毒性肝炎

慢性乙肝完全病毒抑制后体重指数纵向变化与ALT升高的关联

Longitudinal Change of Body Mass Index Is Associated With Alanine Aminotransferase Elevation After Complete Viral Suppression in Chronic Hepatitis B Patients.
PubMed 文献 · J Infect Dis · 2019-01-01

本研究为前瞻性队列,纳入1965例接受核苷(酸)类似物治疗且HBV DNA持续检测不到至少6个月的慢性乙肝患者,每6个月随访。中位随访18.36个月,约三分之一患者出现ALT升高。基线高BMI(≥25 kg/m2)、较年轻年龄和肝硬化独立增加ALT纵向升高风险;随访结束时BMI由高转低者ALT升高风险降低(aOR 0.38,95%CI 0.19-0.77),由低转高者风险增加(aOR 1.78,95%CI 1.02-3.11)。

要点

  • 完全病毒抑制后约1/3慢性乙肝患者仍出现ALT升高。
  • 基线BMI≥25 kg/m2、年轻年龄、肝硬化独立增加ALT升高风险。
  • BMI由高转低可降低ALT升高风险,由低转高则增加风险。

核心结论

  • 高BMI是完全HBV DNA抑制后ALT升高的独立预测因素。
  • 改善BMI可能有助于ALT正常化及长期结局。

研究设计与样本

  • 前瞻性队列研究,纳入1965例接受核苷(酸)类似物治疗且HBV DNA持续检测不到至少6个月的慢性乙肝患者。
  • 每6个月随访,进行人体测量、生化和病毒学评估,中位随访18.36个月。

主要发现

  • 约三分之一患者出现ALT升高。
  • 基线高BMI(≥25 kg/m2)、较年轻年龄和肝硬化独立增加ALT纵向升高风险。
  • 随访结束时89例(4.8%)由高BMI转为低BMI,92例(5.0%)由低BMI转为高BMI。
  • 与持续高BMI相比,转为低BMI降低ALT升高风险(aOR 0.38;95%CI 0.19-0.77)。
  • 与持续低BMI相比,转为高BMI增加ALT升高风险(aOR 1.78;95%CI 1.02-3.11)。

临床怎么用

  • 对完全病毒抑制的慢性乙肝患者应关注BMI变化,将其作为ALT升高的可干预因素。
  • 体重管理可能有助于改善ALT正常化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about cause and intervention for alanine aminotransferase (ALT) elevation after complete viral suppression in patients with chronic hepatitis B (CHB). METHODS: In this prospective cohort study, patients with CHB who were treated with nucleos(t)ide analogs and maintained undetectable levels of hepatitis B virus (HBV) deoxyribonucleic acid (DNA) for at least 6 months were enrolled. Patients were followed up at 6-month intervals, and anthropometric, biochemical, and virological assessments were performed. RESULTS: Of 1965 patients with median follow-up of 18.36 months, one third of patients experienced ALT elevation. Baseline high body mass index ([BMI] defined as ≥25 kg/m2), younger age, and liver cirrhosis independently increased the risk of longitudinal ALT elevation. At the end of follow-up, 89 (4.8%) patients reverted to low BMI, and 92 (5.0%) developed to high BMI. Compared with persistent high BMI, reversion to low BMI reduced the risk of ALT elevation (adjusted odds ratio [aOR], 0.38; 95% confidence interval [CI], 0.19-0.77); compared with persistent low BMI, onset of high BMI increased the risk of ALT elevation (aOR, 1.78; 95% CI, 1.02-3.11). CONCLUSIONS: High BMI is an independent predictor for ALT elevation after complete HBV DNA suppression. Improvement of BMI may have a beneficial effect on ALT normalization and even long-term outcomes.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Wang K, Lin W, Kuang Z, et al. Longitudinal Change of Body Mass Index Is Associated With Alanine Aminotransferase Elevation After Complete Viral Suppression in Chronic Hepatitis B Patients. J Infect Dis. 2019. PMID: 31370059. doi:10.1093/infdis/jiz326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。